title: MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.
abstract: MyD88 was originally described as a primary response gene up-regulated during myeloid differentiation after IL-6 induction. Later, MyD88 was shown to be a key molecule necessary for IL1, IL18 and Toll-like receptor signaling. Since these receptors recognize abundantly produced cytokines during infection or molecular patterns of pathogens, MyD88 itself was suggested to be an important regulator of the first line of defense against invading pathogens, including the differentiation and maturation of myeloid cells. Here we describe that MyD88 is important for early and late hematopoietic events that occur independently of antigen under steady-state conditions. In MyD88-deficient mice the earliest alteration in hematopoiesis was found at the level of long-term hematopoietic stem cells. Moreover, we found that MyD88 influences not only the development of the myeloid lineage but also the differentiation of B cells. The B cell defect observed in Btk-deficient mice is further enhanced when both molecules, Btk and MyD88, are not expressed. Therefore, MyD88 affects myeloid as well as lymphoid hematopoiesis. Since Btk and MyD88 deficiencies influence differentially myeloid and lymphoid development, both molecules seem to act in different signaling pathways important for appropriate developmental events during myelo- and lymphopoiesis.
authors.affiliation: Ulm University, Institute of Physiological Chemistry D-89081 Ulm, Germany.
authors.forename: Katja
authors.initials: K
authors.lastname: Fiedler
authors.forename: Enikö
authors.initials: E
authors.lastname: Kokai
authors.forename: Susanne
authors.initials: S
authors.lastname: Bresch
authors.forename: Cornelia
authors.initials: C
authors.lastname: Brunner
keywords: Btk; MyD88; hematopoiesis; lymphopoiesis; myelopoiesis